Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) Depreciation & Amortization (CF) (2009 - 2025)

Updated

Sanofi's Depreciation & Amortization (CF) was $2.95 billion in the quarter ended Jun 30, 2026, up 82.0% from $1.62 billion a year earlier and up 629.5% from the prior quarter.

Analysis

Sanofi (SNY) Depreciation & Amortization (CF) (2009 - 2025) Analysis & Trends

On a trailing twelve-month basis, Sanofi's Depreciation & Amortization (CF) was $4.2 billion through Jun 30, 2026, up 17.1% year-over-year; for the year ended Dec 31, 2025, it was $6.42 billion, up 65.3% from the prior year.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 8.9% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Depreciation & Amortization (CF) was $3.88 billion in the year ended Dec 31, 2024 (-19.0%), $4.79 billion in the year ended Dec 31, 2023 (+46.3%), $3.28 billion in the year ended Dec 31, 2022 (-17.4%) and $3.97 billion in the year ended Dec 31, 2021 (-5.4%).
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Depreciation & Amortization (CF) since the quarter ended Jun 30, 2019.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for three straight quarters, with growth averaging 27.1% over the last six quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was the quarter ended Jun 30, 2026 (growth of 82.0%); the worst was the quarter ended Jun 30, 2024 (a decline of 38.4%).
  • Per Business Quant data, SNY's Depreciation & Amortization (CF) in the three quarters before the quarter ended Jun 30, 2026 was $403.91 million (quarter ended Mar 31, 2026), $1.67 billion (quarter ended Dec 31, 2025) and -$817.17 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 2.12 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 194.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 1.93 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 1.62 Bn
10 Sanofi 50.74 Bn 17.26 Bn 10.79 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 367.11 Mn
Dec 31, 2024 1.65 Bn
Mar 31, 2024 356.33 Mn
Dec 31, 2023 1.62 Bn
Mar 31, 2023 397.14 Mn
Dec 31, 2022 1.62 Bn
Mar 31, 2022 405.16 Mn
Dec 31, 2021 1.68 Bn
Mar 31, 2021 418.56 Mn
Mar 31, 2020 405.15 Mn
Mar 31, 2019 414.87 Mn
Dec 31, 2018 1.38 Bn
Dec 31, 2015 1.46 Bn
Dec 31, 2014 1.54 Bn
Dec 31, 2013 1.65 Bn
Dec 31, 2012 1.66 Bn
Dec 31, 2011 1.56 Bn
Dec 31, 2010 1.47 Bn
Dec 31, 2009 1.42 Bn
API Access

Sanofi Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SNY&period=max&api_key=YOUR_API_KEY